Cargando…
Nanoparticles in the clinic
Nanoparticle/microparticle‐based drug delivery systems for systemic (i.e., intravenous) applications have significant advantages over their nonformulated and free drug counterparts. For example, nanoparticle systems are capable of delivering therapeutics and treating areas of the body that other del...
Autores principales: | Anselmo, Aaron C., Mitragotri, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689513/ https://www.ncbi.nlm.nih.gov/pubmed/29313004 http://dx.doi.org/10.1002/btm2.10003 |
Ejemplares similares
-
Nanoparticles in the clinic: An update
por: Anselmo, Aaron C., et al.
Publicado: (2019) -
Nanoparticles in the clinic: An update post COVID‐19 vaccines
por: Anselmo, Aaron C., et al.
Publicado: (2021) -
Viral vector‐based gene therapies in the clinic
por: Zhao, Zongmin, et al.
Publicado: (2021) -
Hydrogels in the clinic
por: Mandal, Abhirup, et al.
Publicado: (2020) -
BioTM Buzz (Volume 5, Issue 3): The Future is Bright
por: Mitragotri, Samir, et al.
Publicado: (2020)